tiprankstipranks
Advertisement
Advertisement

CMPS Stock Latest News

Psychedelic: Jefferies initiates Compass Pathways with a Buy rating
The FlyPsychedelic: Jefferies initiates Compass Pathways with a Buy rating
24h ago
JNJ
CMND
Compass Pathways initiated with a Buy at Jefferies
PremiumThe Fly
Compass Pathways initiated with a Buy at Jefferies
5d ago
JNJ
CMPS
Buy Rating Backed by High Likelihood of COMP360 TRD Approval and Significant Upside from Conservative DCF Valuation
PremiumRatings
Buy Rating Backed by High Likelihood of COMP360 TRD Approval and Significant Upside from Conservative DCF Valuation
5d ago
CMPS
Psychedelic: FDA awards Compass Pathways priority review voucher
PremiumThe Fly
Psychedelic: FDA awards Compass Pathways priority review voucher
8d ago
CMND
CMPS
Analyst Reiterates Buy on COMP360 Amid Accelerated Regulatory Momentum, Maintains $70 Price Target
PremiumRatings
Analyst Reiterates Buy on COMP360 Amid Accelerated Regulatory Momentum, Maintains $70 Price Target
10d ago
CMPS
Oppenheimer says CNPV designation strengthens case for Compass Pathways’ COMP360
PremiumThe FlyOppenheimer says CNPV designation strengthens case for Compass Pathways’ COMP360
14d ago
CMPS
Compass Pathways announces FDA granted NDA rolling review request
Premium
The Fly
Compass Pathways announces FDA granted NDA rolling review request
14d ago
CMPS
Compass Pathways initiated with a Buy at B. Riley
Premium
The Fly
Compass Pathways initiated with a Buy at B. Riley
14d ago
CMPS
Compass Pathways enters collaboration with Osmind
PremiumThe Fly
Compass Pathways enters collaboration with Osmind
17d ago
CMPS
Midday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia
PremiumThe Fly
Midday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia
18d ago
BX
DX
PBM, CMPS, ATAI: Psychedelic Biotech Stocks Soar after White House Order for Faster FDA Reviews
PremiumMarket News
PBM, CMPS, ATAI: Psychedelic Biotech Stocks Soar after White House Order for Faster FDA Reviews
18d ago
PBM
ATAI
Compass Pathways ‘commends’ White House Executive Order to accelerate research
PremiumThe Fly
Compass Pathways ‘commends’ White House Executive Order to accelerate research
19d ago
CMPS
Trump Trade: President to sign order on psychedelic used for PTSD
PremiumThe FlyTrump Trade: President to sign order on psychedelic used for PTSD
21d ago
PBM
SPY
Trump to sign order on psychedelic used for PTSD, CBS News says
Premium
The Fly
Trump to sign order on psychedelic used for PTSD, CBS News says
22d ago
PBM
ATAI
Psychedelic: Clearmind’s CMND-100 meets primary endpoint in trial
Premium
The Fly
Psychedelic: Clearmind’s CMND-100 meets primary endpoint in trial
22d ago
BMY
CMND
Strong Efficacy, Favorable Safety, and Limited Competition Drive Buy Rating on COMPASS Pathways’ COMP360
PremiumRatings
Strong Efficacy, Favorable Safety, and Limited Competition Drive Buy Rating on COMPASS Pathways’ COMP360
1M ago
CMPS
Compass Pathways: Strengthened Balance Sheet, Advancing COMP360 Through Pivotal Milestones Supports Buy Rating
PremiumRatings
Compass Pathways: Strengthened Balance Sheet, Advancing COMP360 Through Pivotal Milestones Supports Buy Rating
1M ago
CMPS
Psychedelic: Compass Pathways, NRx Pharma report earnings results
PremiumThe Fly
Psychedelic: Compass Pathways, NRx Pharma report earnings results
1M ago
ATAI
CMPS
Compass Pathways price target lowered to $18 from $20 at Canaccord
PremiumThe Fly
Compass Pathways price target lowered to $18 from $20 at Canaccord
1M ago
CMPS
Compass Pathways price target raised to $14 from $11 at Stifel
PremiumThe FlyCompass Pathways price target raised to $14 from $11 at Stifel
1M ago
CMPS
Compass Pathways price target lowered to $16 from $18 at Morgan Stanley
Premium
The Fly
Compass Pathways price target lowered to $16 from $18 at Morgan Stanley
1M ago
CMPS
Compass Pathways reports Q4 EPS ($1.00) vs. (63c) last year
Premium
The Fly
Compass Pathways reports Q4 EPS ($1.00) vs. (63c) last year
2M ago
CMPS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >